◆英語タイトル:Laboratorios Farmaceuticos Rovi SA (ROVI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013983
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Laboratorios Farmaceuticos ROVI SA (ROVI) is a drug company that develops and manufactures diagnostic, prescription and over the counter medicinal products. The company’s over the counter products include antiperspirant lotions, food supplements, oral gels, cold and hot bags to relieve pains among others. Its diagnostic products include imaging contrast media and contrast injection systems. ROVI’s prescription products are used in the treatment of diseases such as osteoporosis, chronic obstructive pulmonary disease, degenerative osteoarthritis, coronary artery disease and chronic heart failure among others. The company also provides contract manufacturing services for injectables and solid forms and active pharmaceutical ingredient manufacturing services. It also has operational presence in Italy, the UK, Austria, Ireland, Hungary, Poland, Spain, Portugal and others. ROVI is headquartered in Madrid, Spain.
Laboratorios Farmaceuticos Rovi SA (ROVI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorios Farmaceuticos Rovi SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Rovi Enters into Co-Marketing Agreement with Novartis for Neparvis 11
Orexigen Therapeutics Enters into Distribution Agreement with Laboratorios Farmaceuticos Rovi 12
Laboratorios Farmaceuticos Rovi Enters into Co-Marketing Agreement with Merck Sharp & Dohme for Orvatez 13
ROVI Enters into Agreement with Astellas to Market Volutsa 14
Rovi Enters Into Agreement With Medice Arzneimittel Putter To Commercialize Medicebran And Medikinet 15
Rovi Enters Into Agreement With Novartis Farma To Market Hirobriz Breezhaler And Ulunar Breezhaler 16
Laboratorios Farmaceuticos ROVI Enters Into An Agreement With Farmalider 17
Acquisition 18
Grupo Ferrer Internacional Completes Acquisition Of 50% Stake In Alentia Biotech From Laboratorios Farmaceuticos ROVI 18
Laboratorios Farmaceuticos Rovi SA – Key Competitors 19
Laboratorios Farmaceuticos Rovi SA – Key Employees 20
Laboratorios Farmaceuticos Rovi SA – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 26, 2017: ROVI – First Half 2017 Financial Results 22
Apr 21, 2017: ROVI – First Half 2017 Financial Results 25
Jul 28, 2016: ROVI Reports First Half 2016 Financial Results 28
Apr 27, 2016: Laboratorios Farmaceuticos Rovi: First Quarter 2016 Results 33
Feb 24, 2016: Laboratorios Farmaceuticos Rovi: Full Year 2015 Results 36
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorios Farmaceuticos Rovi SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorios Farmaceuticos Rovi SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratorios Farmaceuticos Rovi SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rovi Enters into Co-Marketing Agreement with Novartis for Neparvis 11
Orexigen Therapeutics Enters into Distribution Agreement with Laboratorios Farmaceuticos Rovi 12
Laboratorios Farmaceuticos Rovi Enters into Co-Marketing Agreement with Merck Sharp & Dohme for Orvatez 13
ROVI Enters into Agreement with Astellas to Market Volutsa 14
Rovi Enters Into Agreement With Medice Arzneimittel Putter To Commercialize Medicebran And Medikinet 15
Rovi Enters Into Agreement With Novartis Farma To Market Hirobriz Breezhaler And Ulunar Breezhaler 16
Laboratorios Farmaceuticos ROVI Enters Into An Agreement With Farmalider 17
Grupo Ferrer Internacional Completes Acquisition Of 50% Stake In Alentia Biotech From Laboratorios Farmaceuticos ROVI 18
Laboratorios Farmaceuticos Rovi SA, Key Competitors 19
Laboratorios Farmaceuticos Rovi SA, Key Employees 20
Laboratorios Farmaceuticos Rovi SA, Other Locations 21
Laboratorios Farmaceuticos Rovi SA, Subsidiaries 21